82 reports

Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Global Major Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ##.

  • Depression
  • United States
  • World
  • Demand
  • Product Initiative

Bipolar Disorder (Manic Depression) - Epidemiology Forecast to 2027 ##.

  • Depression
  • France
  • Germany
  • Italy
  • Spain

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Europe Major Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Europe Bipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Drug A: Company ## ##. ##. ##.

  • Bipolar Disorder
  • Depression
  • Mental Health
  • United States
  • Market Shares

Global Depression Epidemiology and Patient Flow Analysis - 2016 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast
  • related to depression and other mental disorders.
  • According to WHO, depression is the leading cause of disability in

Executive Summary A comprehensive research report that analyses the antidepressant drugs market and the drugs market by Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents,...

  • Depression
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Depression
  • Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder. It is also used to treat depression problems.

About Lifestyle Drugs Market Lifestyle disease is associated with the way an individual or group of people live. Some of the lifestyle diseases include depression, sexual dysfunction, anti-aging, baldness, and obesity. Technavio’s analysts forecast the global lifestyle drugs market to grow at a CAGR of 2.87% during the...

  • Depression
  • Allergan plc
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • TYPES OF DEPRESSION
  • CAUSES & SYMPTOMS OF DEPRESSION

Depression is a serious mood disorder, affecting the ability to think, feel, and handle situations like sleeping, eating, or working. It is a mood disorder that causes a persistent feeling of sadness and loss of interest. It builds up a very negative perspective in the way of thinking in every single thing and damages a person’s ability to...

  • Depression
  • World
  • AstraZeneca PLC
  • Lundbeck Inc.
  • Pfizer Inc.

Physician Views: Can Lundbeck and Otsuka' s newly approved Rexulti compete with branded and generic competition in the schizophrenia and depression markets?

  • Depression
  • Mental Health
  • Pathology
  • Psychotic Disorder
  • United States
  • MHDS - MARKET SIZE AND FORECAST 2017-2022
  • ADVANCES IN TECHNOLOGY IN TREATING MENTAL DISORDERS

About CNS therapeutics CNS therapeutics cater to CNS disorders that affect the structure or function of the brain or spinal cord such as Parkinson’s disease, epilepsy, Alzheimer’s disease, anxiety, depression, and bipolar disorders. Technavio’s analysts forecast the Global CNS therapeutics market to grow at a CAGR...

  • Depression
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.

Global Depressive Disorder Market DataPack (2016-2020) Types of Depression Causes & Symptoms of Depression Global Depressive Disorder Market by Value (2010-2015) Global Depressive Disorder Market Forecast by Value (2016-2020) Global Depressive Disorder Market by Region (2015) G

  • Antipsychotic
  • Depression
  • Therapy
  • World
  • Forecast
  • Depression
  • GLOBAL DEPRESSION SCREENING MARKET FOR DEPRESSION SCREENING TESTS, BY REGION,

Introduction Depression and mental health are the leading cause of disability and ill health across the globe. According to the latest estimations from (World Health Organization) WHO, more than 300 million people are now living having depression with an increase of more than 18% between 2005 and 2015. Depression is a kind of mental condition...

  • Depression
  • North America
  • United States
  • World
  • Demand
  • SUBTYPES OF MAJOR DEPRESSIVE DISORDER
  • PRESENTS THE DISEASE MANAGEMENT MODEL FOR MDD.

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. Similar to other neuropsychiatric disorders, MDD has a multifaceted and varied etiology, and remains poorly understood. The MDD...

  • Depression
  • Alkermes plc
  • Allergan plc
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.

It is a very common condition that affects ## in every ## Americans.

  • Antidepressant
  • Depression
  • Mental Health
  • Therapy
  • Market Size
  • Depression - Dormant Projects
  • Depression - Product Development Milestones

Depression - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Depression - Pipeline Review, H1 2018, provides an overview of the Depression (Central Nervous System) pipeline landscape. Depression is a mood disorder that causes...

  • Depression
  • United States
  • Company
  • Product Initiative
  • Anavex Life Sciences Corp.
  • Target
  • Clinical Trial profile. 45 Trial Title

Post Partum Depression (Maternal Depression / Postnatal Depression) Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Post Partum Depression (Maternal Depression / Postnatal Depression) Global Clinical Trials Review, H1, 2018" provides an overview of Post Partum...

  • Depression
  • Therapy
  • World
  • Product Initiative
  • SAGE Therapeutics
  • LATEST CLINICAL TRIALS NEWS ON TREATMENT RESISTANT DEPRESSION
  • TREATMENT RESISTANT DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018*

Treatment Resistant Depression Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Treatment Resistant Depression Global Clinical Trials Review, H2, 2018" provides an overview of Treatment Resistant Depression clinical trials scenario.This report provides top line...

  • Clinical Trial
  • Depression
  • Therapy
  • World
  • Product Initiative
  • RESPIRATORY DEPRESSION (HYPOVENTILATION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS,
  • Target

Respiratory Depression (Hypoventilation) Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Respiratory Depression (Hypoventilation) Global Clinical Trials Review, H1, 2018" provides an overview of Respiratory Depression (Hypoventilation) clinical trials scenario.This...

  • Depression
  • Therapy
  • World
  • Product Initiative
  • RespireRx Pharmaceuticals Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

PSYCHOTIC MAJOR DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* PSYCHOTIC MAJOR DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* PSYCHOTIC MAJOR DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY P

  • Depression
  • Hormone
  • Hospital
  • World
  • Product Initiative
  • 07. Disorder Overview
  • 06. Introduction

About depression drugs According to the WHO, depression is a common mental disorder that contributes significantly to the global burden of disease. It affects people across communities worldwide. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness,...

  • Depression
  • Actavis plc
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • 07.1 TYPES OF DEPRESSION
  • 07.4 TREATMENT AND MANAGEMENT

About Depression According to the WHO, depression is a common mental disorder which contributes significantly to the global burden of disease. It affects people across communities in the world. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness,...

  • Depression
  • United States
  • Actavis plc
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • 3.6.1 Epidemiological Forecast Insight

PEOPLE WHO SUFFER FROM BED STRUGGLE WITH FEELINGS OF DISGUST AND GUILT, AND FREQUENTLY SUFFER FROM CO-OCCURRING MOOD DISORDERS, SUCH AS DEPRESSION OR ANXIETY.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast
  • 3.1 BIBLIOGRAPHY
  • PREVALENCE OF THE MOST FREQUENT PSYCHIATRIC COMORBIDITIES IN INDIVIDUALS WITH AND WITHOUT

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2025 Summary Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as a mood disorder that may lead to a variety of emotional and physical problems (Mayo Clinic, 2015). MDD is characterized by...

  • Depression
  • Japan
  • United States
  • World
  • Forecast
  • TOP COMPANIES PARTICIPATING IN BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS
  • Latest Clinical Trials News on Bipolar Disorder (Manic Depression)

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017" provides an overview of Bipolar Disorder (Manic Depression) clinical trials scenario. This report provides top line data relating...

  • Bipolar Disorder
  • Clinical Trial
  • Depression
  • Neurology
  • World
  • LIBRA DEEP BRAIN STIMULATION SYSTEM - DEPRESSION
  • LIBRA DEEP BRAIN STIMULATION SYSTEM - DEPRESSION - DEEP BRAIN STIMULATION FOR TREATMENT-RESISTANT DEPRESSION

Summary St. Jude Medical, Inc. (SJM) is a medical device company. It develops and manufactures devices for the cardiac rhythm management, cardiovascular, cardiac surgery and atrial fibrillation therapy areas, and implantable neurostimulation devices for the management of chronic pain. Its major products includes tachycardia implantable...

  • Depression
  • United States
  • GlobalData's company
  • Jude Medical, Inc.
  • Thoratec Corporation